Drug intelligence / Profile preview

Pulmex

Development stage
Unknown
Lead developer
Spirig Pharma Ltd.
Modality
Small Molecules
Administration
Topical
01

Overview

Pulmex is a topical ointment developed and marketed by Spirig HealthCare for the symptomatic treatment of upper respiratory tract diseases, such as the common cold, cough, and catarrh. It is a combination product containing four active ingredients: artificial balsam of Peru, racemic camphor, eucalyptus oil, and rosemary oil. These components work synergistically to facilitate breathing, provide mild antiseptic properties, and act as an expectorant to help clear mucus from the respiratory tract. The ointment is applied topically to the chest and back, where its volatile components are inhaled and its active substances are absorbed through the skin to provide relief from congestion. It is an over-the-counter (OTC) medication approved by Swissmedic in Switzerland.

Brand names
Pulmex
Other names
Pulmex SalbePulmex Ointment
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPV3 (Transient receptor potential vanilloid subtype 3)

Beyond the preview

Go deeper on Pulmex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulmex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call